Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.

Alumkal, Joshi J

Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial. [electronic resource] - Clinical genitourinary cancer 10 2017 - 610-617.e3 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

1938-0682

10.1016/j.clgc.2017.02.007 doi


Administration, Oral
Aged
Aged, 80 and over
Benzamides
Double-Blind Method
Humans
Liver Neoplasms--drug therapy
Lung Neoplasms--drug therapy
Male
Nitriles
Phenylthiohydantoin--administration & dosage
Prognosis
Prostatic Neoplasms, Castration-Resistant--drug therapy
Treatment Outcome